![David Hyman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 31 200 $ in data 31/05/2026
David Hyman is Chief Financial Officer & Secretary at Medicenna Therapeutics Corp.
since 2024.
Former roles include Chief Financial Officer & Secretary at Rakovina Therapeutics, Inc. from 2021 to 2025, Chief Financial Officer & Partner at Tandem Accounting Group Ltd. from 2019 to 2024, Chief Financial Officer at KORT Payments, Inc. from 2016 to 2018, Vice President at Camcor Partners, Inc. from 2008 to 2015, Vice President at Camcor Capital, Inc., Director at Serafina Energy Ltd., Chief Financial Officer, Secretary & Director at HAW Capital Corp., Research Analyst at Raymond James Ltd. (Broker), Senior Manager at Deloitte LLP, Chief Financial Officer at TheraCann International Benchmark Corp., and Chief Financial Officer at Tandem Innovation Group.
Education includes an undergraduate degree from the University of Calgary, conferred in 1995.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/05/2026 | 100.000 ( 0,15% ) | 31 200 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Direttore Finanziario/CFO | 14/02/2024 |
| Società | Posizione | Fine |
|---|---|---|
| RAKOVINA THERAPEUTICS INC. | Direttore Finanziario/CFO | 01/05/2025 |
Tandem Accounting Group Ltd.
 Tandem Accounting Group Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Direttore Finanziario/CFO | 01/01/2024 |
Merrco Payments, Inc.
 Merrco Payments, Inc. Miscellaneous Commercial ServicesCommercial Services Provides omnichannel payment processing services | Direttore Finanziario/CFO | 01/07/2018 |
Camcor Partners, Inc.
 Camcor Partners, Inc. Investment ManagersFinance Alternative investment manager | Corporate Officer/Principal | 01/08/2015 |
Tandem Innovation Group | Direttore Finanziario/CFO | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Camcor Capital, Inc.
 Camcor Capital, Inc. Investment ManagersFinance Camcor Capital Inc invests in both public & private hydrocarbon based energy companies located in Canada. It seeks a seat on the board of directors. | Finance |
Raymond James Ltd. (Broker)
 Raymond James Ltd. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Calgary
 University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camcor Partners, Inc.
Camcor Partners, Inc. Investment ManagersFinance Alternative investment manager | Finance |
Deloitte LLP
 Deloitte LLP Miscellaneous Commercial ServicesCommercial Services Provides audit, consulting, financial advisory, risk management and tax services | Commercial Services |
Serafina Energy Ltd.
 Serafina Energy Ltd. Oil & Gas ProductionEnergy Minerals Produces oil and gas | Energy Minerals |
Tandem Accounting Group Ltd.
Tandem Accounting Group Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
HAW Capital Corp.
 HAW Capital Corp. Financial ConglomeratesFinance Provides investment services | Finance |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Merrco Payments, Inc.
Merrco Payments, Inc. Miscellaneous Commercial ServicesCommercial Services Provides omnichannel payment processing services | Commercial Services |
TheraCann International Benchmark Corp.
 TheraCann International Benchmark Corp. Miscellaneous Commercial ServicesCommercial Services Provides turnkey cultivation and technology solutions | Commercial Services |
Rakovina Therapeutics, Inc.
 Rakovina Therapeutics, Inc. Financial ConglomeratesFinance Develops oncology therapeutics | Finance |
Tandem Innovation Group |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
